Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Leukemia, Myeloid, Acute 28Colorectal Neoplasms 28Neoplasms 26Recurrence 22Neoplasm Metastasis 22Advanced Solid Tumors 20Multiple Myeloma 19Lymphoma, B-Cell 19Breast Neoplasms 16Pancreatic Neoplasms 14Lung Neoplasms 14Glioblastoma 13Carcinoma, Hepatocellular 13Brain Neoplasms 13Lymphoma 12Glioma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Melanoma 11Hematologic Neoplasms 11Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Leukemia 10Prostatic Neoplasms 9Head and Neck Neoplasms 9Advanced Solid Tumor 9Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Esophageal Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Advanced Melanoma × Clear all
NCT07107178 2025-08-06

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Biotroy Therapeutics

Phase 1 Not yet recruiting
58 enrolled
DermatologicOther solid neoplasm

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡